Immucor Acquires Gamma Biologicals
TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
Sapheon Acquired by Covidien plc
TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration
Methode Electronics has Divested Dabir
TM Capital served as exclusive financial advisor to Methode Electronicsin the sale of its Dabir Surfaces business unit to Agiliti
NanoGram Devices Acquired by Greatbatch
TM Capital advised NanoGram Devices Corporation in its sale to Greatbatch, Inc. (NYSE: GB) for $45 million in cash
Vascotube Acquired by Cirtec Medical
TM Capital, together with Oaklins Germany, served as a financial advisor to Vascotube GmbH in its sale to Cirtec Medical Systems LLC, a portfolio company of 3i Group plc (LSE:III)